In 2023, Roche-Genentech will shift toward an entirely open-source infrastructure within clinical trials and #Posit/#RStudio is organising an online event. #stats #rstats
https://posit.co/blog/roche-shifting-to-an-open-source-backbone-in-clinical-trials/
@damiacer Hey @justinwilkins did you see this?
In 2023, Roche-Genentech will shift toward an entirely open-source infrastructure within clinical trials and #Posit/#RStudio is organising an online event. #stats #rstats https://posit.co/blog/roche-shifting-to-an-open-source-backbone-in-clinical-trials/
That's what I was thinking. I think #nlmixr2 would fit right in there. Do you know folks at Roche? We should approach them.
Damiano Cerasuolo
John Harrold
Justin Wilkins